LAST CHANCE TO SAVE! New Trends for Life Sciences at PACK EXPO Southeast
Discover all the latest packaging solutions for life sciences products at the all-new PACK EXPO Southeast in Atlanta, GA, March 10-12, 2025
REGISTER ASAP FOR $30!

Biosimilar sales hurt Merck's bottom line

The sales of this biologic dropped 25% after a less expensive version of it was introduced in Europe.

Once companies, including Hospira and Celltrion Healthcare began selling a biosimilar of the Merck arthritis treatment Remicade in Europe, sales plummeted, according to a report in the Wall Street Journal.

Sales of the drug dropped 25 percent to $455 million for the quarter, Merck told the media outlet.

"Merck officials said Tuesday the company has had success convincing European health systems and doctors to keep existing Remicade patients on the drug," the Wall Street Journal wrote. "But new patients are being steered to the biosimilars, Merck said."

LAST CHANCE TO SAVE! New Tech for Life Sciences at PACK EXPO Southeast
The exciting new PACK EXPO Southeast 2025 unites all vertical markets in one dynamic hub, generating more innovative answers to packaging challenges for life sciences products. Don’t miss this extraordinary opportunity for your business!
REGISTER ASAP FOR $30!
LAST CHANCE TO SAVE! New Tech for Life Sciences at PACK EXPO Southeast